Literature DB >> 1841027

Stepwise increase in plasma insulin and C-peptide concentrations in obese, in obese hypertensive, and in obese hypertensive diabetic subjects.

M Donatelli1, A Scarpinato, M L Bucalo, V Russo, T Iraci, G Vassallo.   

Abstract

Several clinical and epidemiological evidences support the increased risk of cardiovascular disease (CVD) in pathological conditions as obesity, hypertension, non-insulin-dependent diabetes mellitus, which have hyperinsulinemia as a common feature. In this study, we assessed basal plasma insulin (IRI) and C-peptide (CPR) concentrations in 297 volunteers who participated in a survey concerning risk factors of CVD. We found a stepwise increase in fasting insulin and C-peptide levels in normal subjects (IRI 9.10 +/- 0.41 microU/ml; CPR 1.79 +/- 0.08 ng/ml), in obese subjects (IRI 11.31 +/- 0.38 microU/ml; CPR 2.54 +/- 0.07 ng/ml) in obese hypertensive subjects (IRI 14.17 +/- 0.72 microU/ml; CPR 2.64 +/- 0.09 ng/ml), in obese hypertensive diabetic subjects (IRI 22.57 +/- 2.62 microU/ml; CPR 3.33 +/- 0.27 ng/ml). Thus, we found increasing levels of IRI and CPR as normal conditions changed towards progressively more severe pathological conditions. Although several other factors contribute to determine CVD, we conclude that increasing levels of insulin and C-peptide could play an important role in causing CVD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1841027

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  4 in total

Review 1.  Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Authors:  Leigh Anderson
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

2.  Conditions of gestation, childbirth and childhood associated with C-peptide in young adults in the 1982 Birth Cohort in Pelotas-RS; Brazil.

Authors:  Romildo Luiz Monteiro Andrade; Denise Petrucci Gigante; Isabel Oliveira de Oliveira; Bernardo Lessa Horta
Journal:  BMC Cardiovasc Disord       Date:  2017-07-11       Impact factor: 2.298

Review 3.  [C-peptide and cardiovascular mortality: systematic review and meta-analysisPéptido C y mortalidad cardiovascular: revisión sistemática y metanálisis].

Authors:  Romildo Luiz Monteiro Andrade; Gabriela Callo; Bernardo Lessa Horta
Journal:  Rev Panam Salud Publica       Date:  2019-02-07

4.  C-Peptide Promotes Cell Migration by Controlling Matrix Metallopeptidase-9 Activity Through Direct Regulation of β-Catenin in Human Endometrial Stromal Cells.

Authors:  Sana Abdul Khaliq; Zobia Umair; Mi-Ock Baek; Seung Joo Chon; Mee-Sup Yoon
Journal:  Front Cell Dev Biol       Date:  2022-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.